Edesa Biotech, Inc.
EDSA
$2.46
$0.0251.03%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Net Income | -5.92M | -5.84M | -6.11M | -6.17M | -6.93M |
Total Depreciation and Amortization | 137.60K | 163.20K | 184.10K | 186.00K | 187.80K |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | 419.20K | 351.30K | 419.50K | 522.70K | 945.90K |
Change in Net Operating Assets | -1.21M | -400.50K | 504.30K | 571.00K | 403.40K |
Cash from Operations | -6.57M | -5.72M | -5.00M | -4.89M | -5.39M |
Capital Expenditure | -- | -- | -- | -- | -- |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -- | -- | -- | -- | -- |
Cash from Investing | -- | -- | -- | -- | -- |
Total Debt Issued | -- | -- | -- | -- | -- |
Total Debt Repaid | 0.00 | 0.00 | -29.50K | -29.50K | -29.50K |
Issuance of Common Stock | 7.50M | 7.64M | 1.04M | 729.40K | 1.21M |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | 9.88M | 9.88M | 1.54M | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -564.90K | -597.30K | -194.30K | -107.80K | -147.70K |
Cash from Financing | 16.81M | 16.92M | 2.36M | 592.00K | 1.04M |
Foreign Exchange rate Adjustments | 76.10K | -98.00K | -61.30K | -25.90K | -61.00K |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | 10.32M | 11.10M | -2.70M | -4.32M | -4.42M |